Royalty Pharma PLC (RPRX) vs Vertex Pharmaceuticals Incorporated (VRTX)
- Royalty Pharma PLC RPRX 61.29 +2.80%
- Vertex Pharmaceuticals Incorporated VRTX 499.39 −1.84%
Royalty Pharma PLC and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $129.0B against $34.3B — 3.8× the size. Vertex Pharmaceuticals Incorporated trades at the lower P/E: 28.8× against 42.3×. Vertex Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 10.2% against 10.0%. Vertex Pharmaceuticals Incorporated has the higher net margin (35.0% vs 32.0%) and the higher return on invested capital (24.1% vs 5.28%). Across the 22 metrics below, Vertex Pharmaceuticals Incorporated leads on 15 and Royalty Pharma PLC on 7.
Valuation
Profitability
| Metric | RPRX | VRTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 86.00% | 65.16% |
| Operating margin | 59.61% | 37.95% | 0.00% |
| Net margin | 32.02% | 35.00% | 0.00% |
| Free cash flow margin | 51.66% | 30.16% | 0.00% |
| Return on equity | 8.42% | 23.54% | (56.36%) |
| Return on assets | 4.26% | 17.12% | (48.04%) |
| Return on invested capital | 5.28% | 24.09% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack